Food and Drug Law Weekly

Callisto Pharmaceuticals - Callisto announces sponsored lab study agreement with M. D. Anderson

Case Western Reserve University, Ohio - Tissue-engineered calcium alginate patches repair chronic tympanic membrane perforations

Case Western Reserve University, U.S. - New findings in cardiology described from the United States, Netherlands and France

Centers for Disease Control and Prevention, U.S. - Injection drug use is strongest risk factor for hepatitis C infection in U.S.

Central Institute of Epidemiology, Russian Federation - Researchers from the Russian Federation, Kenya and Brazil describe findings in meningitis studies

Centre Rene Gauducheau, Nantes, France - Rectal cancer survival decreased after delay of more than 16 weeks between diagnosis and surgery

Chang Gung Memorial Hospital, Taoyuan, Taiwan - Lung tumors in cancer models show Phyllanthus urinaria cuts tumorigenesis and angiogenesis.

Chiba University, Japan - Squamous cell carcinoma adenoviral p53 gene therapy evaluated

China Health Holding - China Health Holding announces consultancy agreement with MT Global Executives

Chung Shan Medical University, Taiwan - Findings from Taiwan, the United States and the United Kingdom advance knowledge in diabetes research

Chung Shan Medical University, Taiwan - Recent findings from Taiwan, the United States and Japan illuminate research in genetics

Chungbuk National University, South Korea - Researchers from South Korea, Japan and United States publish new studies and findings in the area of diabetes

Cincinnati Children's Hospital Medical Center, Cincinnati, U.S. - Current treatments for congenital aortic stenosis are considered in review

City University of New York - Research from the United States and Switzerland add new data to HIV/AIDS body of knowledge

Clavis Pharma - Clavis Pharma receives clearance to begin phase I clinical trial with novel cancer drug CP-4126

Cleveland Clinic Foundation, U.S. - Post-heart attack patients with cardiogenic shock have improved survival with aggressive treatment

Cobalis - Cobalis provides update on clinical program for PreHistin

CombinatoRx - CombinatoRx reports phase II data on CRx-150 in inflammatory disease model

Cook Urological - Emerging urological technologies addressed at Cook VISTA

Cytos Biotechnology - Cytos Biotechnology updates on development of allergy vaccine

Dalhousie University, Canada - Natural health products for osteoporosis prevention and treatment are focus of review

Dana-Farber Cancer Institute, U.S. - Researchers' data from the United States advance HIV/AIDS research

Dartmouth College, U.S. -  Salmonella contamination remains a persistent problem in ground beef

Delmarva Foundation, U.S. - Delmarva Foundation celebrates achievements of hospitals in 100,000 Lives Campaign

Dokuz Eylul University, Turkey - Erectile dysfunction associated with benign prostatic hyperplasia potential treatments are tested

European Society for Human Reproduction and Embryology - Identity fraud a growing concern among clinics providing in vitro fertilization procedures

Food and Drug Administration, U.S. - Method to analyze veterinary drug residues in shrimp has been developed

Hemispherx Biopharma - Hemispherx advances influenza vaccine/immunopotentiation clinical trials

Locus Pharmaceuticals - Locus Pharmaceuticals submits IND on cancer drug candidate, LP-261

Meridian Bioscience - U.S. Food and Drug Administration grants CLIA waiver status for Meridian Bioscience's stomach ulcer test

Millennium Pharmaceuticals - SNDA filed for bortezomib compound for injection in treating relapsed mantle cell lymphoma

University of Puerto Rico - Studies from the United Kingdom, United States and India add new findings to dengue fever body of knowledge

VasoGenix Pharmaceuticals - VasoGenix Pharmaceuticals elects Jerome A. Halperin to company's board of directors

World Health Organization - Ebola virus antibodies detected in oral fluid when RT-PCR is positive